| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |